Table 2. Lyon VTE risk score system by Dargaud et al.
Risk factor | Venous thromboembolism | Score |
---|---|---|
Personal history of VTE | History of VTE related to pregnancy (occurred during the antepartum period), or cerebral vein thrombosis or massive PE/VTE in childhood | 6 |
Spontaneous or estrogen induced PE or proximal DVT | 3 | |
Transient risk factor induced PE or proximal DVT | 2 | |
Spontaneous or estrogen induced distal calf DVT | 2 | |
Transient risk factor induced distal calf DVT | 1 | |
If there is a personal history of VTE | Recurrent VTE history | 3 |
Residual venous thrombi with clinical signs of post thrombotic syndrome | 3 | |
Recent VTE history <2 years | 2 | |
Thrombophilia | Homozygous mutations, combined thrombophilia risk factors, protein C | 1 |
Deficiency, protein S deficiency, heterozygous F5 G1691A mutation | ||
Heterozygous F2 G20210A mutation | ||
No thrombophilia detected but family history of severe recurrent VTE | ||
Other risk factors | Bed rest, immobilization | 2 |
Twin pregnancy | 1 | |
Age >35 | 1 | |
BMI >30 | 1 |
They propose the following depending on the score: <3 no antenatal prophylaxis; 3–5 LMWH starting on the third trimester; ≥6 LMWH starting during the first trimester. VTE, venous thromboembolism; DVT, deep venous thrombosis; LMWH, low molecular weight heparin.